Back to Search
RACHEL HEIST, MD
MD
Pediatrics Physician
NPI: 1720610884Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
33954(NE)
Research & Publications (20)
p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma.
PMID 19302219·Dis Esophagus·2010
8-other
p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis.
PMID 19383811·Clin Cancer Res·2009
4-observational
Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis.
PMID 19321798·Carcinogenesis·2009
8-other
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.
PMID 19667264·J Clin Oncol·2009
8-other
EGFR-targeted therapies in lung cancer: predictors of response and toxicity.
PMID 19102716·Pharmacogenomics·2009
6-review
Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes.
PMID 19620936·Pharmacogenet Genomics·2009
8-other
Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis.
PMID 19584152·Clin Cancer Res·2009
8-other
Genome-wide analysis of survival in early-stage non-small-cell lung cancer.
PMID 19414679·J Clin Oncol·2009
4-observational
Epidermal growth factor A61G gene polymorphism, gastroesophageal reflux disease and esophageal adenocarcinoma risk.
PMID 19520791·Carcinogenesis·2009
4-observational
A rapid outcomes ascertainment system improves the quality of prognostic and pharmacogenetic outcomes from observational studies.
PMID 18199725·Cancer Epidemiol Biomarkers Prev·2008
3-trial
A phase II study of gefitinib in patients with advanced thyroid cancer.
PMID 17985985·Thyroid·2008
3-trial
Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk.
PMID 17957785·Int J Cancer·2008
8-other
VEGF polymorphisms and survival in early-stage non-small-cell lung cancer.
PMID 18281657·J Clin Oncol·2008
8-other
Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer.
PMID 18936471·J Clin Oncol·2008
8-other
A phase II study of oxaliplatin, pemetrexed, and bevacizumab in previously treated advanced non-small cell lung cancer.
PMID 18827612·J Thorac Oncol·2008
3-trial
Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk.
PMID 18780893·Carcinogenesis·2008
8-other
Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer.
PMID 18757527·Carcinogenesis·2008
8-other
MDM2 promoter polymorphism and pancreatic cancer risk and prognosis.
PMID 18559624·Clin Cancer Res·2008
8-other
Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk.
PMID 18478337·Cancer Causes Control·2008
8-other
Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma.
PMID 18253117·Br J Cancer·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 590 MEDICAL CENTER ROAD
FORT HOOD, TX 76544 - Phone
- (254) 288-8888
Quick Facts
- NPI
- 1720610884
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile